Medindia
Medindia LOGIN REGISTER
Advertisement

Visionsense Announces Food and Drug Administration (FDA) 510(k) Clearance for VSII - Visionsense Stereoscopic Vision System

Wednesday, March 19, 2008 General News
Advertisement
ORANGEBURG, N.Y., March 18 Visionsense Corp. announces FDA510(k) Clearance of the new VSII -- Visionsense Stereoscopic Vision System.The system is based on a miniature 3.4 mm distal ("chip-on-a-stick")stereoscopic 3D camera targeting Minimal Invasive laparoscopic and endoscopicSurgery (MIS).
Advertisement

Visionsense's stereoscopic 3D camera enables and enhances MIS surgicalprocedures that are under served by traditional 2D visualization, in marketssuch as: Spine, Neurosurgery, Orthopedics, Endoscopy, General Surgery, GYN,Robotics, and others.
Advertisement

The company has licensed the technology to various strategic marketingpartners, expecting launches later this year.

About Visionsense Corp.

Visionsense exclusively licenses its technology, application or segmentspecific, to strategic partners, benefiting a unique competitive advantage.The Company develops and manufactures customized Miniature Stereoscopic 3Dcameras/sensors that enable surgeons to see "natural" Stereovision, thusenhancing image understanding and hand-eye coordination. These re-useable ordisposable cameras are distally assembled on the tip of a flexible / rigidscope or instrument. The technology further assists the surgeon by providingadvanced software features, such as image fusion (combining stereovision withMRI, CT or ultrasound for real-time "see-through-tissue") and 3D measurements.For more information please call: Joe Rollero Executive Vice President Business Development Visionsense Corp. 40 Ramland Road, Suite 202 Orangeburg, NY 10962 Phone: 845-680-0233 Email: [email protected] www.visionsense.com

SOURCE Visionsense Corp.
Sponsored Post and Backlink Submission


Latest Press Release on General News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close